logo

For the Inventor, By the Inventor

Milan, Italy

Aurelio Di Marco

USPTO Granted Patents = 15

Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 155(Granted Patents)


Company Filing History:

goldMedal11 out of 48 
 
Societa' Farmaceutici Italia
 patents
silverMedal4 out of 208 
 
Farmitalia Carlo Erba
 patents

Years Active: 1977-1982

Loading Chart...
15 patents (USPTO):Explore Patents
1. 4325946 - Anthracycline glycosides, their preparation, use and compositions thereof (1982-04-20),
2. 4276289 - Antitumor glycosides, their preparation and use (1981-06-30),
3. 4254110 - Pentofuranosyl anthracyclines, intermediates in and method for their (1981-03-03),
4. 4183919 - Antitumor glycosides, process for their preparation including (1980-01-15),
5. 4125607 - Daunosaminyl anthracyclinones and their use (1978-11-14),
6. 4112076 - Epi-daunomycin and epi-adriamycin compounds and method of use (1978-09-05),
7. 4098798 - Adriamycins, process for their preparation and uses thereof (1978-07-04),
8. 4067969 - Anthracycline glycosides, their preparation and use (1978-01-10),
9. 4067968 - Daunosamine nucleosides (1978-01-10),
10. 4058519 - Adriamycins and uses thereof (1977-11-15),
11. 4046878 - Daunomycin analogues, their preparation and use (1977-09-06),
12. 4039663 - Daunomycins, process for their uses and intermediates (1977-08-02),
13. 4031211 - Adriamycin esters, their preparation and use (1977-06-21),
14. 4024224 - 14-Aminodaunomycins, their preparation and use (1977-05-17),
15. 4012284 - Process of preparation of antibiotic F.I. 1762 derivatives (1977-03-15),

Title: Innovator Aurelio Di Marco: Pioneering Antitumor Research

Introduction

Aurelio Di Marco, a distinguished inventor based in Milan, Italy, has made significant contributions to the field of pharmaceuticals with a focus on developing innovative treatments for cancer. With a total of 15 patents to his name, Di Marco has dedicated his career to enhancing therapeutic options for patients suffering from mammalian tumors.

Latest Patents

Among his latest patents, Di Marco has pioneered the development of anthracycline glycosides, which are crucial in cancer treatment. His patent titled "Anthracycline glycosides, their preparation, use and compositions thereof" details a method of synthesizing these compounds by condensing daunomycinone with novel sugars in a controlled environment. This innovative process results in unique glycosides that exhibit potential antitumor properties. Another significant patent, "Antitumor glycosides, their preparation and use," describes a similar synthesis process, specifically utilizing a distinct sugar derivative. These formulations are geared towards treating various mammalian tumors, representing a crucial advancement in oncological therapies.

Career Highlights

Throughout his career, Di Marco has worked with well-known pharmaceutical companies, including Società Farmaceutici Italia S.p.A. and Farmitalia Carlo Erba S.p.A. His work in these organizations has greatly influenced the research and development of effective treatments aimed at combating cancer.

Collaborations

Aurelio Di Marco has collaborated with esteemed colleagues such as Federico Maria Arcamone and Sergio Penco, both of whom are recognized for their contributions to pharmaceutical research. These collaborations have enhanced the innovation process, allowing for the exchange of ideas and technical expertise in the development of therapeutic agents.

Conclusion

Aurelio Di Marco's innovative approach to cancer treatment through anthracycline glycosides showcases the impact of dedicated inventors in the pharmaceutical industry. With his extensive patent portfolio and notable collaborations, Di Marco continues to push the boundaries of medical science, striving for breakthroughs that can ultimately improve patient outcomes in cancer care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…